This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04632/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB04632/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB04632/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04632/identifier/drugbank/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04632/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04632
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB04632 n11:DB04632
dcterms:title
4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE
adms:identifier
n4:5287728 n10:4450038 n12:DB04632 n13:46508738 n14:B11
n5:IUPAC-Name
n6:271B4504-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B450A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4509-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4506-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4507-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4508-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4502-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4503-363D-11E5-9242-09173F13E4C5 n6:271B4500-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4501-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4510-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4511-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B450B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B450C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B450E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B450D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B450F-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4516-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4518-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4519-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4515-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4514-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4517-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4505-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4512-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4513-363D-11E5-9242-09173F13E4C5